Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17256834rdf:typepubmed:Citationlld:pubmed
pubmed-article:17256834lifeskim:mentionsumls-concept:C0376515lld:lifeskim
pubmed-article:17256834lifeskim:mentionsumls-concept:C1332397lld:lifeskim
pubmed-article:17256834lifeskim:mentionsumls-concept:C1522538lld:lifeskim
pubmed-article:17256834lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:17256834lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:17256834lifeskim:mentionsumls-concept:C1554184lld:lifeskim
pubmed-article:17256834pubmed:issue4lld:pubmed
pubmed-article:17256834pubmed:dateCreated2007-2-15lld:pubmed
pubmed-article:17256834pubmed:abstractTextOverexpression of the antiapototic proteins Bcl-2 and Bcl-xL provides a common mechanism through which cancer cells gain a survival advantage and become resistant to conventional chemotherapy. Inhibition of these prosurvival proteins is an attractive strategy for cancer therapy. We recently described the discovery of a selective Bcl-xL antagonist that potentiates the antitumor activity of chemotherapy and radiation. Here we describe the use of structure-guided design to exploit a deep hydrophobic binding pocket on the surface of these proteins to develop the first dual, subnanomolar inhibitors of Bcl-xL and Bcl-2. This study culminated in the identification of 2, which exhibited EC50 values of 8 nM and 30 nM in Bcl-2 and Bcl-xL dependent cells, respectively. Compound 2 demonstrated single agent efficacy against human follicular lymphoma cell lines that overexpress Bcl-2, and efficacy in a murine xenograft model of lymphoma when given both as a single agent and in combination with etoposide.lld:pubmed
pubmed-article:17256834pubmed:languageenglld:pubmed
pubmed-article:17256834pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17256834pubmed:citationSubsetIMlld:pubmed
pubmed-article:17256834pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17256834pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17256834pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17256834pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17256834pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17256834pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17256834pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17256834pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17256834pubmed:statusMEDLINElld:pubmed
pubmed-article:17256834pubmed:monthFeblld:pubmed
pubmed-article:17256834pubmed:issn0022-2623lld:pubmed
pubmed-article:17256834pubmed:authorpubmed-author:NgShi-ChungSClld:pubmed
pubmed-article:17256834pubmed:authorpubmed-author:PetrosAndrew...lld:pubmed
pubmed-article:17256834pubmed:authorpubmed-author:FesikStephen...lld:pubmed
pubmed-article:17256834pubmed:authorpubmed-author:DingHongHlld:pubmed
pubmed-article:17256834pubmed:authorpubmed-author:RosenbergSaul...lld:pubmed
pubmed-article:17256834pubmed:authorpubmed-author:KunzerAaronAlld:pubmed
pubmed-article:17256834pubmed:authorpubmed-author:WendtMichael...lld:pubmed
pubmed-article:17256834pubmed:authorpubmed-author:ZhangHaichaoHlld:pubmed
pubmed-article:17256834pubmed:authorpubmed-author:WangXiluXlld:pubmed
pubmed-article:17256834pubmed:authorpubmed-author:ElmoreSteven...lld:pubmed
pubmed-article:17256834pubmed:authorpubmed-author:OostThorsten...lld:pubmed
pubmed-article:17256834pubmed:authorpubmed-author:SongXiaohongXlld:pubmed
pubmed-article:17256834pubmed:authorpubmed-author:JosephMary...lld:pubmed
pubmed-article:17256834pubmed:authorpubmed-author:McClellanWill...lld:pubmed
pubmed-article:17256834pubmed:authorpubmed-author:OltersdorfTil...lld:pubmed
pubmed-article:17256834pubmed:authorpubmed-author:ShoemakerAlex...lld:pubmed
pubmed-article:17256834pubmed:authorpubmed-author:BrunckoMilanMlld:pubmed
pubmed-article:17256834pubmed:authorpubmed-author:ParkCheol-Min...lld:pubmed
pubmed-article:17256834pubmed:authorpubmed-author:BelliBarbara...lld:pubmed
pubmed-article:17256834pubmed:authorpubmed-author:NimmerPaul...lld:pubmed
pubmed-article:17256834pubmed:authorpubmed-author:MittenMichael...lld:pubmed
pubmed-article:17256834pubmed:authorpubmed-author:MartineauDarl...lld:pubmed
pubmed-article:17256834pubmed:issnTypePrintlld:pubmed
pubmed-article:17256834pubmed:day22lld:pubmed
pubmed-article:17256834pubmed:volume50lld:pubmed
pubmed-article:17256834pubmed:ownerNLMlld:pubmed
pubmed-article:17256834pubmed:authorsCompleteYlld:pubmed
pubmed-article:17256834pubmed:pagination641-62lld:pubmed
pubmed-article:17256834pubmed:meshHeadingpubmed-meshheading:17256834...lld:pubmed
pubmed-article:17256834pubmed:meshHeadingpubmed-meshheading:17256834...lld:pubmed
pubmed-article:17256834pubmed:meshHeadingpubmed-meshheading:17256834...lld:pubmed
pubmed-article:17256834pubmed:meshHeadingpubmed-meshheading:17256834...lld:pubmed
pubmed-article:17256834pubmed:meshHeadingpubmed-meshheading:17256834...lld:pubmed
pubmed-article:17256834pubmed:meshHeadingpubmed-meshheading:17256834...lld:pubmed
pubmed-article:17256834pubmed:meshHeadingpubmed-meshheading:17256834...lld:pubmed
pubmed-article:17256834pubmed:meshHeadingpubmed-meshheading:17256834...lld:pubmed
pubmed-article:17256834pubmed:meshHeadingpubmed-meshheading:17256834...lld:pubmed
pubmed-article:17256834pubmed:meshHeadingpubmed-meshheading:17256834...lld:pubmed
pubmed-article:17256834pubmed:meshHeadingpubmed-meshheading:17256834...lld:pubmed
pubmed-article:17256834pubmed:meshHeadingpubmed-meshheading:17256834...lld:pubmed
pubmed-article:17256834pubmed:meshHeadingpubmed-meshheading:17256834...lld:pubmed
pubmed-article:17256834pubmed:meshHeadingpubmed-meshheading:17256834...lld:pubmed
pubmed-article:17256834pubmed:meshHeadingpubmed-meshheading:17256834...lld:pubmed
pubmed-article:17256834pubmed:meshHeadingpubmed-meshheading:17256834...lld:pubmed
pubmed-article:17256834pubmed:meshHeadingpubmed-meshheading:17256834...lld:pubmed
pubmed-article:17256834pubmed:year2007lld:pubmed
pubmed-article:17256834pubmed:articleTitleStudies leading to potent, dual inhibitors of Bcl-2 and Bcl-xL.lld:pubmed
pubmed-article:17256834pubmed:affiliationCancer Research, Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064, USA.lld:pubmed
pubmed-article:17256834pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:17256834lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17256834lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17256834lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17256834lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17256834lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17256834lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17256834lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17256834lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17256834lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17256834lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17256834lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17256834lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17256834lld:pubmed